113 related articles for article (PubMed ID: 86633)
21. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
22. Human melanoma and leukemia associated antigens difined by nonhuman primate antisera.
Seigler HF; Metzgar RS; Mohanakumar T; Stuhlmiller GM
Fed Proc; 1975 Jul; 34(8):1642-6. PubMed ID: 805717
[TBL] [Abstract][Full Text] [Related]
23. A monoclonal antibody to myelogenous leukemia: isolation and characterization.
Malcolm AJ; Shipman RC; Logan PM; Levy JG
Exp Hematol; 1984 Aug; 12(7):539-47. PubMed ID: 6589167
[TBL] [Abstract][Full Text] [Related]
24. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
Negoro S; Seon BK
Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
[TBL] [Abstract][Full Text] [Related]
25. Cloning of human lymphocytes reactive with autologous leukemia cells.
Csako G; Binder RA; Kales AN; Neefe JR
Cancer Res; 1980 Sep; 40(9):3218-21. PubMed ID: 6159073
[TBL] [Abstract][Full Text] [Related]
26. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
Ball ED; Kadushin JM; Schacter B; Fanger MW
J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
[TBL] [Abstract][Full Text] [Related]
27. Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
Houtenbos I; Westers TM; Dijkhuis A; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA
Clin Cancer Res; 2007 Jan; 13(1):307-15. PubMed ID: 17170077
[TBL] [Abstract][Full Text] [Related]
28. Specificities of heterologous antisera against human leukaemia cells. 1. Reactions against leukaemia cells.
Thränhardt H; Milleck J; Zintl F; Koppitz D; Plenert W; Raderecht C; Richter KV
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):463-74. PubMed ID: 83265
[TBL] [Abstract][Full Text] [Related]
29. Serologic studies of the diagnosis and nosology of human leukemia.
Metzgar RS; Mohanakumar T
Am J Clin Pathol; 1977 Nov; 68(5 Suppl):699-705. PubMed ID: 411368
[TBL] [Abstract][Full Text] [Related]
30. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
31. Human leukemia-associated antigens: detection on cells of established lymphoblastoid lines.
Mohanakumar T; Pauly JL; Sokal JE; Metzgar RS
J Immunol; 1975 Dec; 115(6):1542-8. PubMed ID: 171308
[TBL] [Abstract][Full Text] [Related]
32. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.
Hast R; Dowding C; Robak T; Goldman JM
Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449
[TBL] [Abstract][Full Text] [Related]
33. Human leukemia-associated antigen: relation to a family of surface glycoproteins.
Pesando JM; Ritz J; Levine H; Terhorst C; Lazarus H; Schlossman SF
J Immunol; 1980 Jun; 124(6):2794-9. PubMed ID: 6989907
[TBL] [Abstract][Full Text] [Related]
34. Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro.
Sondel PM; O'Brien C; Porter L; Schlossman SF; Chess L
J Immunol; 1976 Dec; 117(6):2197-203. PubMed ID: 1069027
[TBL] [Abstract][Full Text] [Related]
35. [Immunologic phenotype of blast cells in the diagnosis of myeloblastic leukemias].
Baryshnikov AIu; Volkova MA; Frenkel' MA; Tupitsyn NN; Morozova LF
Ter Arkh; 1985; 57(5):98-100. PubMed ID: 3895550
[TBL] [Abstract][Full Text] [Related]
36. Human granulocyte antigens detected on leukemia cells and a chronic myelogenous cell line.
Drew SI; Billing R; Bergh OJ; Terasaki PI
Vox Sang; 1978; 34(1):1-7. PubMed ID: 74903
[TBL] [Abstract][Full Text] [Related]
37. A human alloantiserum precipitates Ia-like molecules from chronic lymphocytic leukemia cells.
Nilsson S; Schwartz BD; Waxdal M; Green E; Cullen SE; Mann DL
J Immunol; 1977 Apr; 118(4):1271-4. PubMed ID: 66283
[TBL] [Abstract][Full Text] [Related]
38. Specificities of heterologous antisera against human leukaemia cells. 2. Reactions against fetal liver cells and absorption studies with fetal tissue.
Thränhardt H; Zintl F; Milleck J; Koppitz D; Plenert W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):475-83. PubMed ID: 83266
[TBL] [Abstract][Full Text] [Related]
39. Antisera against leukaemia-associated antigens on human lymphocytes.
Hsu CC; Marti GE; Mittal KK
Clin Exp Immunol; 1977 Mar; 27(3):487-96. PubMed ID: 301073
[TBL] [Abstract][Full Text] [Related]
40. Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. II. Detection by human anti-B-cell alloantisera.
Billing R; Ting A; Terasaki PI
J Natl Cancer Inst; 1977 Feb; 58(2):199-203. PubMed ID: 64614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
